Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 01, 2007 (Vol. 27, No. 3)


  • Disease-focused
  • Poor educational content
Cadasil is a hereditary disease affecting the brain, but I had a hard time understanding exactly what it is from this site covering it. A description at the top of the opening page provides a clue, as well as considerable confusion. Here is what it says, “CADASIL . . . is a heredity disease that affects the muscle walls in the small arteries that provide blood flow to the brain. The gene prohibits the body from making a protein; this allows the small blood vessels to be defective. The blood vessels are so small they cannot be detected by the naked eye.” Got that? The site aims to educate and provide awareness, support, and research on the subject. It also contains a fact sheet and a list of places where research is ongoing. If you have the syndrome, you’ll probably find the site of use. If you’re looking for education, however, you’ll be disappointed.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »